Daiichi Sankyo, in collaboration with AMDA Multisectoral and Integrated Development Services, launched a campaign titled “Promotion of the Non-Communicable Diseases (NCDs) control in Madagascar.”
In Madagascar, NCDs, such as hypertension, diabetes, cervical cancer, and breast cancer, pose a serious public health challenge. As of 2018, NCDs accounted for 43% of all causes of death, affecting people of all ages and genders.
In particular, the target area of Manjakandriana District, services and access for NCDs prevention and care are extremely limited. There is a shortage of trained personnel with experience in cancer screening, as well as insufficient equipment and supplies, making it impossible to conduct screenings effectively.
To address these challenges, the project focuses on the Manjakandriana District in Analamanga Region, aiming to create an environment where local residents can actively engage in NCDs prevention, early detection, and management. This will be achieved through awareness-raising activities and strengthening screening systems, ultimately improving overall health conditions.
Through these activities, we will contribute to the achievement of Sustainable Development Goal 3: “Ensure healthy lives and promote well-being for all at all ages”.
Project overview:
- Region: Manjakandriana District, Analamanga Region, Madagascar
- Activity summary:
1) Ensure an enabling environment for NCDs.
2) Reduce NCDs risk factors by promoting healthy lifestyle among local residents.
3)Improve access to the prevention and early detection of NCDs.
- Duration: 3 years (July 2025 to Jun 2028)
- Collaborative partner: AMDA Multisectoral and Integrated Development Services*1
*1 AMDA-Multisectoral and Integrated Development Services:
An organization that addresses the improvement of livelihoods in the world's impoverished communities through the development of human resources and villages.
https://www.amda-minds.org/english/
As a pharmaceutical company with the purpose, to “contribute to the enrichment of quality of life around the world,” the Daiichi Sankyo Group is committed to resolving healthcare access issues in regions with limited healthcare infrastructure.